Multiple central giant cell tumour lesions are exclusively linked to syndromes related to RAS/MAPK pathway anomalies

We read the article entitled “SH3BP2-encoding exons involved in cherubism are not associated with central giant cell granuloma” by Teixeira et al. with great interest . They claim that SH3BP2-encoding exons, as involved in cherubism, are not associated with central giant cell granuloma (CGCG). However, only patients with a solitary lesion were included in their study. In the case of multiple lesions, we have observed a relationship with cherubism and RASopathies. Extensive reviews on these conditions have been published by Hyckel et al. and Rauen .

An analysis of all 58 patients with CGCG seen in our department identified 16 patients with multiple lesions. Details of these 16 patients are given in Table 1 below.

Table 1
Characteristics of the 16 patients with multiple central giant cell granuloma lesions.
Sex Age, years Symptoms Genetic analysis
Female 13 Noonan syndrome PTPN11 mutation
Male 8 Noonan syndrome SOS1 mutation
Female 13 Noonan syndrome No KRAS/PTPN11/HRAS/SOS1 mutations detected
Male 10 Noonan syndrome with multiple lentigines PPN11 mutation
Male 5 Cherubism SH3PB2 mutation
Female 6 Cherubism SH3PB2 mutation
Male 14 Cherubism SH3-adjacent mutation
Female 4 Cherubism SH3PB2 mutation
Male 5 Cherubism SH3PB2 mutation
Male 12 Cherubism No SH3PB2 mutation detected
Female 3 Cherubism SH3PB2 mutation
Male 11 Cherubism SH3PB2 mutation
Female 9 Cherubism No SH3PB2 mutation detected
Female 14 Cherubism Not done
Female 6 Cherubism Not done
Female 24 Neurofibromatosis NF1 mutation
Only gold members can continue reading. Log In or Register to continue

Stay updated, free dental videos. Join our Telegram channel

Dec 14, 2017 | Posted by in Oral and Maxillofacial Surgery | Comments Off on Multiple central giant cell tumour lesions are exclusively linked to syndromes related to RAS/MAPK pathway anomalies

VIDEdental - Online dental courses

Get VIDEdental app for watching clinical videos